[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Monday, 23 July 2007, 13:32 GMT 14:32 UK
New move towards Alzheimer's cure
Elderly woman
The number of people with Alzheimer's is expected to rise
A group of Fife scientists believe they have moved a step closer to finding a cure for Alzheimer's disease.

St Andrews University biologists claim to have developed a compound which has successfully prevented the disease killing brain cells.

It also appeared to improved memory and learning ability already damaged.

Working with US researchers they developed man-made compounds capable of blocking a nerve cell interaction known to lead to the symptoms of the disease.

The results of the study - carried out in the laboratory using a model of the disease - have prompted the Alzheimer's Research Trust to help fund a further three years research.

Trust chief executive Rebecca Wood described the findings as "exciting".

"A drug that can stop Alzheimer's disease from killing brain cells is a holy grail for researchers working to overcome the devastating condition which affects more than 500,000 people in the UK," she said.

Our research holds a possible key for the treatment of Alzheimer's disease, particularly in its early stages
Dr Gunn-Moore
St Andrews University

The number of sufferers is expected to double to more than one million with the general ageing of the population over the next generation.

Alzheimer's is linked to the build-up of amyloid protein, which eventually forms "senile plaques".

The amyloid protein inflicts damage by interacting with an enzyme called amyloid beta alcohol dehydrogenase (ABAD) and releasing toxic substances which kill brain cells.

Researchers at St Andrews University initially focused on developing the three-dimensional shape of ABAD and understanding how amyloid attaches itself to the structure.

Living model

Dr Frank Gunn-Moore, senior lecturer at the university's school of biology, said: "Alzheimer's sufferers produce too much amyloid and ABAD in their brains.

"Based on our knowledge of ABAD, we produced an inhibitor that can prevent amyloid attaching to it in a living model."

Dr Gunn-Moore, who led the research, added: "We have shown that it is possible to reverse some of the signs associated with Alzheimer's disease.

"The work is now being continued to try and refine the inhibitor into a potential drug.

"Our research holds a possible key for the treatment of Alzheimer's disease, particularly in its early stages."

Dr Susanne Sorensen, head of research, Alzheimer's Society, said: "The study provides another important piece in the puzzle for understanding Alzheimer's disease and points toward a possible new treatment target, which has so far been unexplored."

Jim Jackson, chief executive of Alzheimer Scotland, also welcomed the results of the study, although he cautioned that more research was required.

Alzheimer's disease
08 Jan 04 |  Medical notes
'You are just left alone'
27 Feb 07 |  Health
Singer Melly has early dementia
27 Feb 07 |  Health
Are you worried by dementia figures?
27 Feb 07 |  Have Your Say
Call for improved dementia care
22 Nov 06 |  Health

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Americas Africa Europe Middle East South Asia Asia Pacific